Literature DB >> 35035755

Progressive osseous heteroplasia: a case report and literature review.

Keyun Zhang1, Hairong Tang1, Renming Zhang1, Yongchao Wang1, Qin Su1, Xin Lin1, Qiang Tian1, Sheng Cao1, Meichun Fu1, Jian Zhu1, Xiaoqing Shen1, Feng Li1.   

Abstract

OBJECTIVE: To investigate the clinical features and pathogenesis of progressive osseous heteroplasia (POH) in children.
METHODS: The clinical features and imaging findings of a child with POH are described, and family investigations and gene comparisons were performed, followed by a literature review.
RESULTS: A 9-year-old female with no relevant family medical history initially presented with ectopic ossification of the skin and subcutaneous tissue of the right face that developed slowly. The ossification area extended to the right waist, back, and right knee. The unilateral body (limbs) was gradually invaded. The patient exhibited limited movement of the head, neck, and left shoulder joint, and experienced difficulty in opening her mouth. She also exhibited deformity of the toe, delayed development, insufficient language skills and behavioral ability, and difficulty in communicating with others, but had no apparent endocrine disorders. Blood calcium, phosphorus, and alkaline phosphatase levels were normal, and DNA sequencing did not yield a positive result.
CONCLUSION: The clinical manifestations of POH include hard plaques, which can develop deep into the bone; however, there are currently no effective preventive or treatment measures. AJTR
Copyright © 2021.

Entities:  

Keywords:  Progressive dysplasia of bone; children; plaques

Year:  2021        PMID: 35035755      PMCID: PMC8748116     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  18 in total

Review 1.  Progressive osseous heteroplasia.

Authors:  F S Kaplan; E M Shore
Journal:  J Bone Miner Res       Date:  2000-11       Impact factor: 6.741

Review 2.  Progressive osseous heteroplasia: an uncommon cause of ossification of soft tissues.

Authors:  C Stoll; M R Javier; J P Bellocq
Journal:  Ann Genet       Date:  2000 Apr-Jun

3.  Progressive osseous heteroplasia. Report of a family.

Authors:  J A Urtizberea; H Testart; F Cartault; L Boccon-Gibod; M Le Merrer; F S Kaplan
Journal:  J Bone Joint Surg Br       Date:  1998-09

4.  Progressive osseous heteroplasia in a Chinese infant and a novel mutation in the GNAS gene.

Authors:  S-D Zhang; Z-L Xie; K-Q Zhang; K Nh-Tseung; J-J Zhao
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-12-26       Impact factor: 6.166

5.  Progressive osseous heteroplasia caused by a mosaic GNAS mutation.

Authors:  Arrate Pereda; Jose Maria Martos-Tello; Intza Garin; Javier Errea-Dorronsoro; Guiomar Perez de Nanclares
Journal:  Clin Endocrinol (Oxf)       Date:  2018-03-25       Impact factor: 3.478

Review 6.  Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow-up of three previously reported cases.

Authors:  F S Kaplan; R Craver; G D MacEwen; F H Gannon; G Finkel; G Hahn; J Tabas; R J Gardner; M A Zasloff
Journal:  J Bone Joint Surg Am       Date:  1994-03       Impact factor: 5.284

7.  The level of sonic hedgehog signaling regulates the complexity of cerebellar foliation.

Authors:  JoMichelle D Corrales; Sandra Blaess; Eamonn M Mahoney; Alexandra L Joyner
Journal:  Development       Date:  2006-03-29       Impact factor: 6.868

8.  Progressive osseous heteroplasia in the face of a child.

Authors:  Russell A Faust; Eileen M Shore; Christopher E Stevens; Meiqi Xu; Shefali Shah; C Douglas Phillips; Frederick S Kaplan
Journal:  Am J Med Genet A       Date:  2003-04-01       Impact factor: 2.802

Review 9.  GNAS mutations and heterotopic ossification.

Authors:  Murat Bastepe
Journal:  Bone       Date:  2017-09-06       Impact factor: 4.398

Review 10.  Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities.

Authors:  Maurizio Pacifici
Journal:  Curr Opin Pharmacol       Date:  2018-03-31       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.